- MyIllumina
- Tools
Illumina Genotyping Automation Options for Infinium, GoldenGate, and DASL Assays streamline workflow and reduce errors. Illumina Robot Control Software, together with liquid-handling automation, enables seamless automation of sample preparation into the iScan System workflow.
Illumina Genotyping Automation Options are available for Infinium Assay post-amplification protocols and GoldenGate Assay pre- and post-PCR protocols. The LIMS-Ready Automation Option is ideally suited for managing large whole-genome association studies using the iScan System and Infinium Option Package. Liquid-handling robots are equipped with robotic arm capabilities that are barcode reader-ready for LIMS sample tracking.
- The GoldenGate Genotyping and Infinium Automation Package
This package includes a Tecan Freedom EVO 150 liquid handler with LiHa and a PC workstation programmed with Illumina's Robot Control software.
- The LIMS-ready GoldenGate and Infinium Genotyping Automation Package
This package includes a Tecan Freedom EVO 150 with a RoMa, custom barcode reader for scanning BeadChips, and a PosID system with barcode scanner for scanning reagents, as well as the PC workstation.
View the System Components Chart.
Catalog IDs: SC-30-401, SC-30-402, SC-30-403, SC-30-404
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.